These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 199498)

  • 1. Regulation of liver lipid metabolism in experimental obesity [proceedings].
    Jeanrenaud B; Freychet P; Assimacopoulos-Jeannet F; le Marchand Y; Karakash C
    Biochem Soc Trans; 1977; 5(4):890-4. PubMed ID: 199498
    [No Abstract]   [Full Text] [Related]  

  • 2. The hormonal and metabolic basis of experimental obesity.
    Assimacopoulos-Jeannet F; Jeanrenaud B
    Clin Endocrinol Metab; 1976 Jul; 5(2):337-65. PubMed ID: 182419
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid metabolism in genetic models of obesity.
    York DA
    Proc Nutr Soc; 1975 Dec; 34(3):249-55. PubMed ID: 174122
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of carbohydrate and lipid metabolism in the liver and adipose tissue of normal and diabetic mice.
    Loten EG; Assimacopoulos-Jeannet F; Le Marchand Y; Singh A; Jeanrenaud B
    Adv Enzyme Regul; 1974; 12():45-71. PubMed ID: 4376897
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
    Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
    Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrogen handling in adult hypothalamic obese rats.
    Karakash C; Rohner-Jeanrenaud F; Hustvedt BE; Jeanrenaud B
    Am J Physiol; 1980 Jan; 238(1):E32-7. PubMed ID: 7356014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of insulin removal by perfused liver from spontaneously obese rats.
    Weiland D; Mondon CE; Reaven GM
    Diabetologia; 1979 Mar; 16(3):173-7. PubMed ID: 428687
    [No Abstract]   [Full Text] [Related]  

  • 8. Nutritionally induced variations in insulinaemia, blood ketone bodies and plasma and liver triglycerides in genetically obese rats.
    Malewiak MI; Griglio S; Mackay S; Lemonnier D; Rosselin G
    Diabete Metab; 1977 Jun; 3(2):81-9. PubMed ID: 196951
    [No Abstract]   [Full Text] [Related]  

  • 9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathology of lipid metabolism and liver changes in obesity].
    Cotrozzi G; Relli P; Cersosimo R; Venturi M; Rossi M
    Clin Ter; 1995; 146(8-9):483-90. PubMed ID: 8536431
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
    Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
    Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams.
    Bouanane S; Merzouk H; Benkalfat NB; Soulimane N; Merzouk SA; Gresti J; Tessier C; Narce M
    Metabolism; 2010 Dec; 59(12):1701-9. PubMed ID: 20494379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.
    de Guia RM; Rose AJ; Sommerfeld A; Seibert O; Strzoda D; Zota A; Feuchter Y; Krones-Herzig A; Sijmonsma T; Kirilov M; Sticht C; Gretz N; Dallinga-Thie G; Diederichs S; Klöting N; Blüher M; Berriel Diaz M; Herzig S
    EMBO J; 2015 Feb; 34(3):344-60. PubMed ID: 25510864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin.
    Bourgeois CS; Wiggins D; Hems R; Gibbons GF
    Am J Physiol; 1995 Aug; 269(2 Pt 1):E208-15. PubMed ID: 7653537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    Nuotio-Antar AM; Hachey DL; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin.
    Wiegman CH; Bandsma RH; Ouwens M; van der Sluijs FH; Havinga R; Boer T; Reijngoud DJ; Romijn JA; Kuipers F
    Diabetes; 2003 May; 52(5):1081-9. PubMed ID: 12716736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism: insights into the complexity of VLDL metabolic pathways.
    Sparks CE; Sparks JD
    Curr Opin Lipidol; 2010 Jun; 21(3):280-1. PubMed ID: 20463474
    [No Abstract]   [Full Text] [Related]  

  • 18. U-14C]fructose and lipid metabolism in the perfused rat liver [proceedings.
    Laker ME; Mayes PA
    Biochem Soc Trans; 1979 Dec; 7(6):1279-81. PubMed ID: 231529
    [No Abstract]   [Full Text] [Related]  

  • 19. Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling.
    Costandi J; Melone M; Zhao A; Rashid S
    Circ Res; 2011 Mar; 108(6):727-42. PubMed ID: 21293001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride turnover in health and disease.
    Steiner G
    Can Med Assoc J; 1979 Oct; 121(8):1072-3. PubMed ID: 232425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.